HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Scanning the ocular albinism 1 (OA1) gene for polymorphisms in congenital nystagmus by DHPLC.

AbstractBACKGROUND:
Nystagmus is common to all types of albinism. Some subjects with nystagmus lack convincing signs of albinism, have no other visual pathway disease, and are classified as possessing congenital idiopathic nystagmus (CN). It has been postulated that CN may be a form of ocular albinism.
METHODS:
The presence of nystagmus, iris transillumination, and visual acuity were recorded in 39 CN and albino patients and their families. Physical characteristics were also noted. DNA from buccal swabs was obtained for use in denaturing high performance liquid chromatography (DHPLC) and chemical cleavage of mismatch (CCM) to scan several hotspots for X-linked ocular albinism (OA1) mutations.
RESULTS:
Two previously reported polymorphisms were confirmed: neither was found to be a causative mutation.
CONCLUSION:
No correlation was identified between nystagmus and OA1.
AuthorsGeorgina B Sallmann, Paula J Bray, Sophie Rogers, Anne Quince, Richard G H Cotton, Susan M Carden
JournalOphthalmic genetics (Ophthalmic Genet) Vol. 27 Issue 2 Pg. 43-9 (Jun 2006) ISSN: 1381-6810 [Print] England
PMID16754205 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Eye Proteins
  • GPR143 protein, human
  • Membrane Glycoproteins
Topics
  • Albinism, Ocular (genetics)
  • Chromatography, High Pressure Liquid (methods)
  • Exons (genetics)
  • Eye Proteins (genetics)
  • Female
  • Genetic Testing
  • Humans
  • Male
  • Membrane Glycoproteins (genetics)
  • Mutation
  • Nystagmus, Congenital (genetics)
  • Polymorphism, Genetic
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sequence Analysis, DNA

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: